Albiglutide Thorough ECG Study in Healthy Volunteers

Clinical trial NCT01406262 · COMPLETED

Trial details

NCT number: NCT01406262
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2011-07-06
Primary completion: 2011-12-29
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.